04/24/2025 8:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/11/2025 3:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/11/2025 3:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/07/2025 4:25 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2025 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025 8:13 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/16/2025 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
01/06/2025 9:40 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for NRSNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
12/26/2024 3:47 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
12/23/2024 8:04 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2024 10:06 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 1:42 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
12/12/2024 4:08 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/04/2024 7:32 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 3:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/24/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
11/22/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
10/31/2024 3:59 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
10/01/2024 5:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 8:24 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024 8:29 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024 8:11 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 7:05 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Watch This Robotics Demo Before July 23rd (Ad) Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%...
Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo… |
06/27/2024 7:20 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/27/2024 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:16 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/24/2024 8:20 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:42 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 4:24 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/17/2024 4:25 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/17/2024 4:22 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 6:14 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
05/20/2024 3:16 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-1/A | |
05/20/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 9:21 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |